<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Bullman S</submitter><funding>NCATS NIH HHS</funding><funding>Clark Family Fund for GI Cancer Research</funding><funding>Howard Hughes Medical Institute</funding><funding>Project P Fund for Colorectal Cancer Research</funding><funding>National Institutes of Health</funding><funding>Hale Family Center for Pancreatic Cancer</funding><funding>Prevent Cancer Foundation</funding><funding>Cellex Private Foundation</funding><funding>Chambers Family Fund for Colorectal Cancer Research</funding><funding>DF/HCC GI SPORE P50</funding><funding>Banco Bilbao Vizcaya Argentaria Foundation</funding><funding>Stand-up-to-Cancer</funding><funding>National Institute of Health</funding><funding>Team Perry Fund</funding><funding>NCI NIH HHS</funding><funding>American Cancer Society Research Professorship</funding><pagination>1443-1448</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC5823247</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>358(6369)</volume><pubmed_abstract>Colorectal cancers comprise a complex mixture of malignant cells, nontransformed cells, and microorganisms. &lt;i>Fusobacterium nucleatum&lt;/i> is among the most prevalent bacterial species in colorectal cancer tissues. Here we show that colonization of human colorectal cancers with &lt;i>Fusobacterium&lt;/i> and its associated microbiome-including &lt;i>Bacteroides&lt;/i>, &lt;i>Selenomonas&lt;/i>, and &lt;i>Prevotella&lt;/i> species-is maintained in distal metastases, demonstrating microbiome stability between paired primary and metastatic tumors. In situ hybridization analysis revealed that &lt;i>Fusobacterium&lt;/i> is predominantly associated with cancer cells in the metastatic lesions. Mouse xenografts of human primary colorectal adenocarcinomas were found to retain viable &lt;i>Fusobacterium&lt;/i> and its associated micro</pubmed_abstract><journal>Science (New York, N.Y.)</journal><pubmed_title>Analysis of &lt;i>Fusobacterium&lt;/i> persistence and antibiotic response in colorectal cancer.</pubmed_title><pmcid>PMC5823247</pmcid><funding_grant_id>CA127003</funding_grant_id><funding_grant_id>R35 CA197735</funding_grant_id><funding_grant_id>CA148894</funding_grant_id><funding_grant_id>R35 CA197568</funding_grant_id><funding_grant_id>UL1 TR001102</funding_grant_id><funding_grant_id>Figdor Family Fellowship</funding_grant_id><funding_grant_id>UL1 TR001863</funding_grant_id><funding_grant_id>CA169141</funding_grant_id><funding_grant_id>K07 CA148894</funding_grant_id><funding_grant_id>CA205406</funding_grant_id><funding_grant_id>R01 CA118553</funding_grant_id><funding_grant_id>CA197735</funding_grant_id><funding_grant_id>R01 CA205406</funding_grant_id><funding_grant_id>CA118553</funding_grant_id><funding_grant_id>CA197568</funding_grant_id><funding_grant_id>P50 CA127003</funding_grant_id><funding_grant_id>R01 CA169141</funding_grant_id><pubmed_authors>Fasani R</pubmed_authors><pubmed_authors>Elez E</pubmed_authors><pubmed_authors>Sicinska E</pubmed_authors><pubmed_authors>Mulet N</pubmed_authors><pubmed_authors>Pedamallu CS</pubmed_authors><pubmed_authors>Huang K</pubmed_authors><pubmed_authors>Nuciforo P</pubmed_authors><pubmed_authors>Hagan T</pubmed_authors><pubmed_authors>Ramon Y Cajal S</pubmed_authors><pubmed_authors>Bullman S</pubmed_authors><pubmed_authors>Cai D</pubmed_authors><pubmed_authors>Ramachandran A</pubmed_authors><pubmed_authors>Aguirre AJ</pubmed_authors><pubmed_authors>Hahn WC</pubmed_authors><pubmed_authors>Ng K</pubmed_authors><pubmed_authors>Clancy TE</pubmed_authors><pubmed_authors>Walker M</pubmed_authors><pubmed_authors>Serna G</pubmed_authors><pubmed_authors>Tabernero J</pubmed_authors><pubmed_authors>Landolfi S</pubmed_authors><pubmed_authors>Ogino S</pubmed_authors><pubmed_authors>Chipashvili O</pubmed_authors><pubmed_authors>Neuberg D</pubmed_authors><pubmed_authors>Nelson T</pubmed_authors><pubmed_authors>Guevara F</pubmed_authors><pubmed_authors>Zhang X</pubmed_authors><pubmed_authors>Fuchs CS</pubmed_authors><pubmed_authors>Meyerson M</pubmed_authors><pubmed_authors>Diosdado B</pubmed_authors></additional><is_claimable>false</is_claimable><name>Analysis of &lt;i>Fusobacterium&lt;/i> persistence and antibiotic response in colorectal cancer.</name><description>Colorectal cancers comprise a complex mixture of malignant cells, nontransformed cells, and microorganisms. &lt;i>Fusobacterium nucleatum&lt;/i> is among the most prevalent bacterial species in colorectal cancer tissues. Here we show that colonization of human colorectal cancers with &lt;i>Fusobacterium&lt;/i> and its associated microbiome-including &lt;i>Bacteroides&lt;/i>, &lt;i>Selenomonas&lt;/i>, and &lt;i>Prevotella&lt;/i> species-is maintained in distal metastases, demonstrating microbiome stability between paired primary and metastatic tumors. In situ hybridization analysis revealed that &lt;i>Fusobacterium&lt;/i> is predominantly associated with cancer cells in the metastatic lesions. Mouse xenografts of human primary colorectal adenocarcinomas were found to retain viable &lt;i>Fusobacterium&lt;/i> and its associated micro</description><dates><release>2017-01-01T00:00:00Z</release><publication>2017 Dec</publication><modification>2026-05-05T03:44:03.249Z</modification><creation>2019-03-27T00:11:24Z</creation></dates><accession>S-EPMC5823247</accession><cross_references><pubmed>29170280</pubmed><doi>10.1126/science.aal5240</doi></cross_references></HashMap>